homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

July 18, 2012

Dendreon

Seattle-based Dendreon Corp. said John Johnson, president and CEO, is now also chairman of the board. Johnson succeeds Dr. Mitchell Gold, who will continue to serve as director. Dendreon is a biotech company focused on cancer.




Email or user name:
Password:
 
Forgot password? Click here.